License-In
Summary of 8 newly published patent applications are added to "Patent Portfolio"
We released the summary of 8 newly published patent applications from our "Patent Portfolio" as follows. AJ165 Method for producing low-anti...
License-In
We released the summary of 8 newly published patent applications from our "Patent Portfolio" as follows. AJ165 Method for producing low-anti...
results 41 - 50 of 231
Other
Our office will be closed for winter holidays from Saturday 26th December 2020 to Sunday 3rd January 2021. Please understand that our earlie...
License-Out
We have executed a non-exclusive license agreement with Eyestem Research Private Limited (Bengaluru, India) for the use of iPS cell-derived ...
License-Out
We have executed a non-exclusive license agreement with Meatable BV (Delft, Netherlands) for allowing the manufacture and sale of cultured m...
License-In
We released the summary of 4 newly published patent applications from our "Patent Portfolio" as follows. AJ208 Method for producing hepatocy...
License-Out
We have executed a non-exclusive license agreement with TOKU-E EU NV (East Flanders, Belgium) for allowing them to provide services using iP...
License-Out
We have executed an exclusive license agreement with xFOREST Therapeutics ( Kyoto city, Japan ) to conduct development and marketing of prod...
License-Out
We have executed a non-exclusive license agreement with T&R Biofab Co., Ltd. (Gyeonggi-do, Republic of Korea) for allowing them to provi...
License-Out
We have executed a non-exclusive license agreement with Elixirgen Scientific, Inc. (Baltimore, MD, U.S.A.) for allowing them to sell iPS ce...
Management Information
Kyoto University acquires all voting stocks of iPS Academia Japan, Inc. in August 2020, and iPS Academia Japan, Inc. became its subsidiary....